Posts Tagged ‘Sarepta Therapeutics Inc. (SRPT)’
Hedge Fund and Insider Trading News: George Soros, Ray Dalio, Ken Griffin, Daniel Och, EDL Capital, Rokos Capital Management, Precigen Inc (PGEN), Sigilon Therapeutics, Inc. (SGTX), and More
George Soros has been branded as a bogeyman by the right wing for backing liberal causes around the globe.
Hedge Fund and Insider Trading News: Ray Dalio, Svelland Global Trading Fund, Glen Point Capital, V2X Inc (VVX), Tesla, Inc. (TSLA), and More
Sept 15 (Reuters) - Billionaire Ray Dalio, founder of one of the world's biggest hedge funds, has predicted a sharp plunge in stock markets as the U.S.
Hedge Fund and Insider Trading News: Anthony Scaramucci, Michael Burry, Ken Griffin, Tudor Jones, Third Point LLC, Oasis Management, Sarepta Therapeutics Inc (SRPT), Summit Therapeutics Inc. (SMMT), and More
The selloff in crypto, as well as the broader market downturn, has left Anthony Scaramucci’s SkyBridge Capital’s flagship fund of funds down 25 percent for the year through...
Hedge Fund and Insider Trading News: Dalton Investments, Balyasny Asset Management, Livermore Partners, IsZo Capital Management, Sarepta Therapeutics Inc (SRPT), Tabula Rasa HealthCare Inc (TRHC), and More
Dalton Investments, a $3.4 billion U.S. investment firm, says it’s still on the fence over whether to support Shinsei Bank Ltd.’s management or SBI Holdings Inc.
12 Best Genomic Stocks to Buy Now
In this article, we present to you the 12 best genomic stocks to buy now according to hedge funds.
12 Best Large Biotech Stocks to Buy Now
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions.
The 25 Biggest Insider Purchases in October
Insider purchases consistently outpaced insider sales during much of October, the first time that has happened over a minimum two-week period since January 2016.
Here’s What Is Going On In The Financial Markets Today?
"U.S. stocks traded firmly higher Wednesday, with the Nasdaq Composite setting an intraday record, after a strong reading on private-sector hiring in March.
Why Sarepta Therapeutics Inc (SRPT) Shares Are Surging
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have popped 4% after Edward Nash of SunTrust upgraded the equity to 'Buy' from 'Hold' and set a $45 target price.
What Do Hedge Funds Think of Sarepta Therapeutics Inc (SRPT)?
In a rather quiet market where the Dow is down but the S&P and NASDAQ are both up, Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have rallied 3%, showing some solid relative...
Sarepta Therapeutics Inc (SRPT) Gets Off To A Running Start With Eteplirsen
Sarepta Therapeutics Inc (NASDAQ:SRPT) is one of the week’s biggest winners from the J.P.
5 Medical Tech Stocks You Should Be Investing In
The medical sector is growing rapidly and getting in on the ground floor with med tech can be highly profitable for smart investors, but how can you know which stocks to choose...
Sarepta Therapeutics Inc. (SRPT) Stock: Jason Karp Is A Shareholder Again And Has A Larger Position Than Ever
Jason Karp's Tourbillon Capital Partners has retaken a stake in Sarepta Therapeutics Inc (NASDAQ:SRPT) after having sold off its previous position in the stock during the second...
Sarepta Therapeutics Inc (SRPT) Stock: “Eteplirsen Approval Controversy Rages On”
If you follow Sarepta Therapeutics Inc (NASDAQ:SRPT), you know about Eteplirsen. The treatment is designed to treat several diseases, including Duchenne muscular dystrophy.
Today’s Trending Stocks: Sarepta, Humana, HTG Molecular Diagnostics, and More
After yesterday's rather sharp fall, Wall Street is quiet today as the Dow is up only 14 points while the NASDAQ is 0.01% in the green. In this article, we analyze some stocks...
Why Sarepta Therapeutics, Ralph Lauren, Fifth Third Bancorp, and Two Other Stocks Are in Spotlight on Friday
WTI crude futures have sank below the $50 per barrel mark around noon as traders brace for another potential rise in the rig count.
Here’s Why These Five Stocks Are in the Spotlight Today
In this article, we will analyze five stocks that are showing considerable more movement than the broader market and are attracting more interest, Bassett Furniture Industries...
Here’s Why These Five Stocks Are Trading Higher Today
Broad markets are shaky today with NASDAQ trading in red territory.
Rite Aid Corporation, WCI Communities & Other Stocks in Spotlight Following Earnings, M&A News and More
Wall Street is quiet today after the Federal Reserve's Wednesday decision of keeping interest rates the same.
NASH Hype Has These 2 Stocks Soaring, Plus the Latest On MGT Capital, PTC Therapeutics, and Cloud Peak Energy
There is little fear on the Street today, as all three major indexes are moderately higher.
Sarepta Soars to 150% Q3 Gains, Wal-Mart Closes Jet Deal, SeaWorld Sinks & More
Among the stocks capturing attention from traders early this morning are SeaWorld Entertainment Inc (NYSE:SEAS), Ascena Retail Group Inc (NASDAQ:ASNA), Wal-Mart Stores, Inc.
Sarepta Therapeutics Inc (SRPT), PTC Therapeutics, Inc. (PTCT) and More: Here’s Why These Stocks Are on Investors’ Radars Today
Wall Street is in bull mode today as all three major indexes are in the green, with the Dow rising 90 points, the S&P 500 increasing 0.5% and the NASDAQ inching up 0.4%.
Why Sarepta, Glu Mobile, Harmony Gold and 2 Other Stocks Are On The Move Today
Some stocks are nonetheless gaining ground this morning, including Sarepta Therapeutics Inc (NASDAQ:SRPT), At Home Group Inc.
Summit Therapeutics PLC (ADR) (SMMT) Is Hot On Sarepta Therapeutics Inc (SRPT)’s DMD Tail
Duchenne’s Muscular Dystrophy (DMD) is a hot topic right now.
Why GE, Yahoo, and 3 Other Stocks Are Trending This Morning
The markets are in the green ahead of Tuesday's opening bell, with the S&P, Nasdaq, and Dow futures are all in positive territory, as are crude futures.
Why AMD, Hovnanian, and Three Other Stocks Are Down Today
The markets have been quiet so far today, amid news involving the ADP private payrolls rising by 173,000 for May and OPEC agreeing to maintain the status quo.
Why Facebook, Opower, Genworth, Apollo Education, and Sarepta Are Spiking Today
Even though oil is down on Monday, U.S stocks are up, partly driven by strength in the financial and consumer discretionary sectors.
Why Are Investors Piling Into These Surging Stocks?
Although the Dow Jones Index and the S&P 500 are each close to flat for the day, shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Textura Corp (NYSE:TXTR), Cliffs Natural...
Why You Should Watch These Five Stocks Today?
Markets opened higher on Tuesday as companies continue to announce quarterly financial results. A Federal Reserve policy meeting is also scheduled to start today.
Here’s Why These 5 Stocks Are Deep in the Red Today
Although crude futures have rallied to almost break-even and most of the major earnings reports released so far aren't sharply negative in terms of those company's macro-economic...
Two Healthcare Companies and One Micro-Cap Company Register Strong Insider Buying
Piggybacking insider trading has been a profitable investment strategy over the past several decades or so based on research, though new regulations and an increased use of stock...
Top Biotech Picks of Best-Performing Hedge Fund of 2015
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top of the list was biotech...
Four of the Biggest Movers on a Volatile Friday Morning
Market fear just isn't going away. With S&P futures down by 2% in the pre-market and crude prices breaking below $30 per barrel, Friday looks to be another volatile day.
Here’s Why These Five Stocks Are Plunging Today
With markets slightly in the red on Wednesday, a number of stocks stood out as they are plunging in afternoon trading.
Breaking Down Steve Cohen’s Four Latest Moves in Sarepta Therapeutics (SRPT), Smith & Wesson (SWHC), More
Steve Cohen's Point72 Asset Management has upped its stake in two companies and added two new holdings to its equity portfolio, according to four separate Schedule 13G forms ...
Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It
Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment vehicles of a forgotten age.
Acorda Therapeutics Inc (ACOR): Insiders Aren’t Crazy About It But Hedge Funds Love It
To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age.
Santarus, Inc. (SNTS): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In the financial world, there are a multitude of gauges investors can use to watch publicly traded companies. A couple of the best are hedge fund and insider trading interest.
Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)
If you were to ask many of your fellow readers, hedge funds are seen as overrated, old investment vehicles of a period lost to current times.
Sarepta Therapeutics Inc (SRPT), GlaxoSmithKline plc (ADR) (GSK): An Edge Emerges in the Race to Treat Muscular Dystrophy
In a previous article, I speculated on the race to develop a Duchenne muscular dystrophy, or DMD, drug and who might win it.
GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): Could This DMD Treatment Become a Blockbuster Drug?
Duchenne muscular dystrophy, or DMD, is a muscle-wasting disease caused by a genetic mutation in the dystrophin gene -- the largest gene on the X chromosome -- which affects one...
ChemoCentryx Inc (CCXI), GlaxoSmithKline plc (ADR) (GSK): Horrendous Health-Care Stocks This Week
While many investors worried about the Nasdaq's three-hour shutdown this week, shareholders of a few stocks probably wished it wouldn't have come back up.
What Hedge Funds Think About VIVUS, Inc. (VVUS)
In the 21st century investor’s toolkit, there are dozens of metrics investors can use to track Mr. Market.
Alexion Pharmaceuticals, Inc. (ALXN), Sarepta Therapeutics Inc (SRPT), Regeneron Pharmaceuticals Inc (REGN): Is There Any Remaining Value in This Industry Leader?
At some point, a company reaches a level of maximum valuation. It doesn't mean the company becomes bad, but rather all upside is priced in and future gains are limited.
Sarepta Therapeutics Inc (SRPT), ISIS Pharmaceuticals, Inc. (ISIS): Is Questcor Pharmaceuticals Inc (QCOR) Still Undervalued?
It has been approximately a year since the Citron Research report about Questcor Pharmaceuticals Inc (NASDAQ:QCOR) came out, which caused the stock to lose more than half of its...
GlaxoSmithKline plc (ADR) (GSK), Gilead Sciences, Inc. (GILD): Did Sarepta Therapeutics Inc (SRPT) Just Knock Out Its DMD Competitor?
Ignore the bickering between shareholders of Sarepta Therapeutics Inc (NASDAQ:SRPT) and GlaxoSmithKline plc (ADR) (NYSE:GSK) /Prosensa for a moment, because these are exciting...
